Adicet Bio vs Caris Life Sciences
Adicet Bio vs Caris Life Sciences, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adicet Bio is on 48/100 and Caris Life Sciences on 59/100.
Where each one leads
Adicet Bio
Leads on none of the measures we hold for both companies.
Caris Life Sciences
- our overall score: 59/100 against 48/100
- agent readiness: 47/100 against 23/100
- domain rating: 63/100 against 38/100
- funding raised: $700M against $389M
At a glance
| Measure | Adicet Bio | Caris Life Sciences |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. |
| Category | Biotech, HealthTech, Oncology, Autoimmune Diseases | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2014 | 2008 |
| Headquarters | Boston, United States | Irving, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adicet Bio | Caris Life Sciences |
|---|---|---|
| Employees | Not published | 1,659 |
| Total funding | $389M | $700M |
| Latest round | Registered Direct Offering | Series D |
| Valuation | Not published | $7.8B |
| LinkedIn followers | Not published | 77,698 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adicet Bio | Caris Life Sciences |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 59/100 |
| Traction | 40/100 | 60/100 |
| Team | 50/100 | Not published |
| Community | 8/100 | Not published |
| Search visibility | 19/100 | 22/100 |
| Quality | 58/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (23/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 63/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adicet Bio | Caris Life Sciences |
|---|---|---|
| Hosting | AWS | Self Managed |
| CMS | Not detected | WordPress |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Google Tag Manager |
Adicet Bio vs Caris Life Sciences: common questions
Which is better, Adicet Bio or Caris Life Sciences?
On our 0-100 score Caris Life Sciences rates higher (59/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Adicet Bio and Caris Life Sciences compare on the numbers?
Caris Life Sciences leads on our overall score (59/100 against 48/100), agent readiness (47/100 against 23/100), domain rating (63/100 against 38/100), funding raised ($700M against $389M).
Read the full Adicet Bio review and pricing or the Caris Life Sciences review and pricing. You can also browse other Adicet Bio alternatives we track.